The effects of smoking and its cessation on 8-epi-PGF2α and transforming growth factor-beta 1 in Type 1 diabetes mellitus

Diabetic Medicine

Volumn 21, Issue 3, 2004, Pages 285-289

  Flores, L ^a   Vidal, M ^a   Abian, J ^a   Cases, A ^a   Campistol, J Ma ^a   Claria J ^a   Lario, S ^a   Esmatjes, E ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Diabetes mellitus; Isoprostanes; Tobacco; Transforming growth factor beta 1

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CREATININE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SMOKING CESSATION;

ADULT; COTININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DINOPROST; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; MALE; SMOKING; SMOKING CESSATION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASOCONSTRICTOR AGENTS;

EID: 1542374588     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01133.x     Document Type: Article

References (31)

1. Peto R, Lopez A, Boreham J, Thun M, Heath C, Doll R. Mortality from tobacco in developed countries: indirect estimates from national vital statistics. Lancet 1992; 339: 1268-1278.
2. Scott L, Warram J, Hanna L, Laffel L, Ryan L, Krolewski A. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in Type 1 diabetes. Diabetes 2001; 50: 2842-2849.
3. Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
4. Moy C, Laporte R, Dorman J. Insulin dependent diabetes mellitus mortality: the risk of cigarette smoking. Circulation 1990; 82: 37-43.
5. Sawicki P, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17: 126-131.
6. Forsblom C, Groop P, Ekstrand A, Totterman K, Sane T, Salorenta C et al. Predictors of progression from normoalbuminuria to micro-albuminuria in NIDDM. Diabetes Care 1998; 21: 1932-1938.
7. Church D, Pryor W. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 96: 111-126.
8. Frei B, Forte T, Ames B, Ames B, Cross C. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J 1991; 227: 133-138.
9. 2 isoprostanes) in smokers. NEJM 1995; 332: 1198-1203.
10. Reilly M, Delanty N, Lawson J, FitzGerald G. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25.
11. Baynes J, Thorpe S. Role of oxidative stress in diabetic complications. Diabetes 1999; 48: 1-9.
12. Giuliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
13. Santini S, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana G et al. Defective plasma antioxidant defenses and enhaced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997; 46: 1853-1858.
14. Klahr S. Oxygen radicals and renal diseases. Miner Electrolyte Metab 1997; 23: 140-143.
15. 2-isoprostanes as an index of oxidative stress in vivo. Free Rad Biol Med 2000; 28: 505-513.
16. 2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 1999; 147: 1-10.
17. Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thrombosis Res 2000; 99: 209-221.
18. Sharma K, Ziyadeh F, Alzahabi B, McGowan T, Kappor S, Kurnik B et al. Increased renal production of transforming growth factor TGF-β1 in patients with Type II diabetes. Diabetes 1997; 46: 84-89.
19. Hoffman B, Sharma K, Ziyadeh F. Potential role of TGFβ1 in diabetic nephropathy. Miner Electrolyte Metab 1998; 24: 190-196.
20. Sharma K, Ziyadeh F. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 1995; 44: 1139-1146.
21. 2 isprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental Type 1 diabetes. Kidney Int 2000; 58: 1963-1972.
22. Iglesias-de la Cruz M, Ruiz-Torres P, Alcami J, Diez-Marquez L, Ortega-Velasquez R, Chen S et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int 2001; 59: 87-95.
23. Shen Y, Rattan V, Sultana CH, Kalra V. Cigarette smoke condensate-induced adhesion molecule expression and trans-endothelial migration of monocytes. Am J Physiol 1996; 270: H1624-H1633.
24. Esmatjes E, Flores L, Lario S, Clària J, Cases A, Iñigo P et al. Smoking increases serum levels of transforming growth factor-β in diabetic patients. Diabetes Care 1999; 22: 1915-1916.
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
26. Heatherton T, Kozlowski L, Frecker R, Fagerstrom K. The Fagerström test for nicotine dependence: a revision of the Fargeström Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
27. Ellis D, Forrest K, Erbey J, Orchard T. Urinary measurement of TGF-β and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem 1998; 44: 950-956.
28. Gopaul N, Anggard E, Mallet A, Betteridge D, Wolff S, Nourooz-Zadeh J. Plasma 8-epi-PGF2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995; 368: 225-229.
29. Davì G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S et al. In vivo formation of 8-iso-prostaglandin PGF2α and platelet activation in diabetes mellitus: effects of improved metabolic control. Circulation 1999; 99: 224-229.
30. Cerami C, Found H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S et al. Tobacco smoke is a source of toxic reactive glycation products. Proct Natl Acad Sci USA 1997; 94: 13915-13920.
31. Nicholl ID, Bucala R. Advanced glycation end-products and cigarette smoking. Cell Mol Biol (Noisy-le-Grand), 1998; 44: 1025-1033.